Arch Biopartners Inc (OP: ACHFF )

1.220 USD UNCHANGED

Streaming Delayed Price Updated: 3:29 PM EDT, Oct 20, 2020 Add to My Watchlist

Price and Volume

Volume	0
Open	1.220
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	1.220
Today's Range	1.220 - 1.220
52wk Range	0.5250 - 1.220
Shares Outstanding	58,457,929
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

First Patient Dosed in Phase II Trial to Treat Complications in COVID-19

October 16, 2020

Arch Biopartners Receives Approval from Turkish Ministry of Health to Proceed with Phase II Trial for LSALT Peptide; Begins Screening Patients in Florida

October 07, 2020

Performance

YTD	+64.64%	+64.64%
1 Month	+22.00%	+22.00%
3 Month	+16.19%	+16.19%
6 Month	+87.69%	+87.69%
1 Year	+69.21%	+69.21%

More News

Arch Biopartners Announces Application to the Turkish Ministry of Health to Conduct Phase II Trial for Treatment of Complications in COVID-19 patients

September 01, 2020

Arch Biopartners Obtains DTC Eligibility for its Common Shares on OTCQB

August 21, 2020

Arch Biopartners to Hold LSALT Peptide Webinar and Q&A Session August 18, 2020 at 11am EST

August 07, 2020

Arch Biopartners Receives Independent Institutional Review Board Approval for Phase II Trial for LSALT Peptide

August 04, 2020

Broward Health Medical Center Becomes First Clinical Site in U.S. for Phase II Trial for LSALT Peptide

July 28, 2020

Arch Biopartners Engages Global CRO to Conduct LSALT peptide (Metablok) Phase II trial for Treatment of Complications in COVID-19 Patients in the U.S.

July 14, 2020

FDA Grants Arch Biopartners Permission to Proceed with Phase II trial to Evaluate Metablok (LSALT peptide) for the Treatment of COVID-19 patients

June 16, 2020

Arch Biopartners Announces FDA Acknowledgement of its Investigational New Drug Application for Metablok (LSALT peptide)

June 15, 2020

Arch Biopartners Submits Investigational New Drug Application to the FDA for Metablok (LSALT peptide)

June 08, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.